Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01903330
Title ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Daniela A. Bota
Indications

glioblastoma

high grade glioma

gliosarcoma

Therapies

Bevacizumab

Cyclophosphamide

Sargramostim

Age Groups: adult
Covered Countries USA


No variant requirements are available.